Ye Tian

Mr. Ye Tian


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Medicine
Verified
Journal Article
Open access
JDJieli Du
Jieli Du
TJTianbo Jin
Tianbo Jin
YCYuju Cao
Yuju Cao
JCJunyu Chen
Junyu Chen
YGYongchang Guo
Yongchang Guo
JWJianzhong Wang
Jianzhong Wang
Steroid-induced osteonecrosis of the femoral head (ONFH) is the most common clinical nontraumatic ONFH. Once ONFH occurs, it seriously reduces patients’ quality of life. The matrix metalloproteinase/tissue inhibitor of metalloproteinase (MMP/TIMP) system was found to play a significant role in the development of ONFH. The aim of this study was to identify the associations between 7 genes selected from the MMP/TIMP system and steroid-induced ONFH. We genotyped 34 single-nucleotide polymorphisms (SNPs) of 7 genes selected from the MMP/TIMP system in a case–control study with 285 cases of steroid-induced ONFH and 308 healthy controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using the chi-squared test, genetic model analysis, haplotype analysis, and stratification analysis. We found that the minor alleles of rs1940475 and rs11225395 in MMP8 were associated with a 1.32-fold increased risk of steroid-induced ONFH in the allelic model analysis (P = 0.021 and 0.022, respectively). In the genetic model analysis, we found that rs3740938, rs2012390, rs1940475, and rs11225395 were associated with an increased risk of steroid-induced ONFH. In further stratification analysis, rs3740938 and rs2012390 displayed a significantly increased risk of steroid-induced ONFH in females under the dominant (rs3740938, OR = 2.69, 95% CI: 1.50–4.83, P = 0.001; rs2012390, OR = 2.30, 95% CI: 1.31–4.03, P = 0.012) and additive (rs3740938, OR = 2.02, 95% CI: 1.24–3.29, P = 0.010; rs2012390, OR = 1.77, 95% CI: 1.12–2.80, P = 0.047) models. In addition, haplotype “AGTCA” of MMP8 was found to be associated with a 1.40-fold increased risk of steroid-induced ONFH (95% CI: 1.04–1.88, P = 0.025). Our results verify that genetic variants of MMP8 contribute to steroid-induced ONFH susceptibility in the population of northern China. In addition, we found that gender differences might interact with MMP8 polymorphisms to contribute to the overall susceptibility to steroid-induced ONFH.

15 September 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
JDJieli Du
Jieli Du
WLWanlin Liu
Wanlin Liu
TJTianbo Jin
Tianbo Jin
ZZZhenqun Zhao
Zhenqun Zhao
RBRui Bai
Rui Bai
JWJianzhong Wang
Jianzhong Wang
A single-nucleotide polymorphism in MMP9 is associated with decreased risk of steroid-induced osteonecrosis of the femoral head

5 May 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YTYe Tian
Ye Tian
FAFeimeng An
Feimeng An
JWJiaqi Wang
Jiaqi Wang
CLChang Liu
Chang Liu
HWHuiqiang Wu
Huiqiang Wu
YTYe Tian
Ye Tian
Background. Steroid-induced osteonecrosis of the femoral head is a relatively serious condition which seriously reduces patient quality of life. However, the pathogenesis of steroid-induced ONFH is still unclear. In recent years, more scholars have found that the pathogenesis of steroid-induced ONFH is related to susceptibility factors such asMMPs/TIMPssystem. The main purpose of this study is to investigate the correlation betweenMMP2andMMP10gene polymorphisms and steroid-induced ONFH in Chinese Han population.Methods. Six SNPs inMMP2and two SNPs inMMP10were genotyped using Agena MassARRAY RS1000 system from 286 patients of steroid-induced ONFH and in 309 healthy controls. The association betweenMMP2andMMP10polymorphisms and steroid-induced ONFH risk were estimated by the Chi-squared test, genetic model analysis, haplotype analysis, and stratification analysis. The relative risk was estimated by odd ratios (ORs) and 95% confidence intervals (CIs).Result. We found that the minor TG allele of rs470154 inMMP10was associated with an increased risk of steroid-induced ONFH (OR = 1.45, 95% CI, 1.03 – 2.05,p= 0.032). In the genetic model analysis, we found that rs2241146 inMMP2gene and rs470154 inMMP10gene showed a statistically significant association with increased risk of steroid-induced ONFH. The six SNPs (rs470154, rs243866, rs243864, rs865094, rs11646643, and rs2241146) showed a statistically significant association with different clinical phenotypes.Conclusion. Our results verify that genetic polymorphisms ofMMP2andMMP10contribute to steroid-induced ONFH susceptibility in the population of Chinese Han population, and our study provides new insights into the role thatMMP2andMMP10plays in the mechanism of ONFH.

16 February 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
FAFeimeng An
Feimeng An
JDJieli Du
Jieli Du
YCYuju Cao
Yuju Cao
JSJianping Shi
Jianping Shi
YGYongchang Guo
Yongchang Guo
JWJianzhong Wang
Jianzhong Wang
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Feimeng An1, 2, *, Jieli Du2, *, Yuju Cao3, Jianping Shi4, Yongchang Guo3, Tianbo Jin5, Jian Li3, Junyu Chen1, 2, Ping Li2, Mei Dong2, Guoqiang Wang2, Jianzhong Wang2 1Inner Mongolia Medical University, Hohhot, Inner Mongolia, China 2Department of Orthopedics and Traumatology, The Second Affiliated Hospital of Inner Mongolia University, Hohhot, Inner Mongolia, China 3Zhengzhou TCM Traumatology Hospital, Zhengzhou, Henan, China 4Department of TCM Diagnosis, Inner Mongolia Medical University, Hohhot, China 5MOE Key Laboratory of Resource Biology and Modern Biotechnology, Northwest University, Xi’an, China *These authors contributed equally to this work and should be considered co-first authors Correspondence to: Guoqiang Wang, email: wangguoqianggq@163.com Jianzhong Wang, email: wangjianzhong0503@126.com Keywords: MMP8, single nucleotide polymorphisms, osteonecrosis of the femoral head, association study Received: October 07, 2016 Accepted: January 09, 2017 Published: February 16, 2017

6 November 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
YQYuxin Qi
Yuxin Qi
YZYong Zhu
Yong Zhu
YCYuju Cao
Yuju Cao
HWHuiqiang Wu
Huiqiang Wu
MSMingqi Sun
Mingqi Sun
JWJianzhong Wang
Jianzhong Wang
Association between MMP-3 polymorphisms among Chinese patients with osteonecrosis of the femoral head Association between MMP-3 polymorphisms among Chinese patients with osteonecrosis of the femoral head

20 May 2019 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
SWShanshan Wang
Shanshan Wang
YTYe Tian
Ye Tian
YXYu Xu
Yu Xu
SCShangli Cai
Shangli Cai
JXJianping Xiong
Jianping Xiong
E20510 Background: In non-small cell lung cancer (NSCLC), tumour mutational burden (TMB) has been validated in predicting the clinical benefit of immunotherapy. Smoke, delivering the carcinogens that form covalently bound DNA adducts into respiratory system, is the critical cause of miscoding events and mutational burden in NSCLC. However, the predictive potential of tobacco consumption in immunotherapy remains controversial. Here, we did a meta-analysis to assess the heterogeneity of immune checkpoint inhibitor (ICI) efficacy in NSCLC patients with or without smoking habit. Methods: We systematically searched PubMed, the Cochrane Central library and Embase, for the randomized controlled trials (RCTs) of ICIs (inhibitors of PD-1, PD-L1, CTLA-4, or combination) in NSCLC. The studies were excluded due to the unpublished hazard ratio (HR) for both progression-free survival (PFS) and overall survival (OS) according to smoking status. Pooled estimates of survival HR and 95% confidence interval (CI) in smokers and non-smokers were performed using a random-effects model, and the heterogeneity between the two estimates was assessed using an interaction test by Review Manager. Results: In total, 13 eligible RCTs of FDA-approved ICIs (concerning ipilimumab, nivolumab, pembrolizumab, atezolizumab, and avelumab) containing 8154 patients with NSCLC (6800 [83.4%] smokers and 1354 [16.6%] non-smokers) were included for analysis. Compared to standard treatment, a prolonged PFS was observed in smokers treated with ICIs (pooled HR, 0.72, 95% CI 0.63-0.81, P < 0·001) instead of non-smokers (pooled HR, 0.98, 95% CI 0.73-1.31, P = 0·90). The pooled HR of OS between immunotherapy and standard treatment was 0.77 (95% CI 0.69-0.86, P < 0·001) in smokers and 0.78 (95%CI 0.59-1.02, P = 0·07) in non-smokers. Similar results were observed among sub-groups according to the different histology (squamous and non-squamous), class of ICIs (anti-PD-1 or PD-L1) and lines of treatment (first-line or subsequent). The difference in efficacy between smokers and non-smokers treated with ICIs was also significant (HR 0.75, 95% CI 0.62-0.92, P = 0·005). Conclusions: ICIs can improve PFS and OS for patients with advanced NSCLC, but the magnitude of benefit depends on smoking history, especially for PFS. Future clinical trials are supposed to include more non-smokers and concentrate on enhancing the efficacy of ICIs in the NSCLC patients without cigarette consumption, possibly discovering distinctive immunotherapeutic approaches in smokers and non-smokers.